John C. McKew

All filings by John C. McKew on record concern Lumos Pharma, Inc., in the capacity of senior executive. Over a trading history stretching from 1 April 2020 to 12 December 2024, the count stands at 27 filings.

Every open-market trade on record is a sale: 10 sales worth €97k. Outside the open market, there are 16 share grants. Since January 2024: no purchases and 3 sales on the market.

The newest entry dates from 13 December 2024: a transaction, in Lumos Pharma, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.